Epstein Secrets

Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, P

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, P

agement Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA Valery Gergiev Artistic and General Director Mariinsky Theatre Russian Federation Valerie Germain Managing Partner

Minister of Trade of Australia Chief Executive Officer President and Chief Executive Officer Chief Executive Officer Chief Executive Officer Head, Pharma Division Chief Executive Officer, Asset Management Chairman, President and Chief Executive Officer Editor-in-Chief, Magazines Secretary of Foreign Affairs

f Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Development Managing Director, Marketing Co-Founder and Chief Executive Officer